Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2012

Feb 2, 2012

29819_dirs_2012-02-02_c51fb450-81fb-4d95-8a2c-9694373cb638.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-01-31

Reporting Person: HOOPER ANTHONY C (EVP, Global Commercial Ops.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-01-31 Common Stock A 26497 Acquired 71735 Direct

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 3/2/2012, 3/2/2013 and 3/2/2014, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include the following RSUs granted under the Company's equity plans: 22,619 which fully vest on 3/2/2012; 26,497 RSUs which vest in two equal installments of 8,744 each on 3/2/2012 and 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.